Clinical Trial Update: Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing panitumumab plus GEMOX versus GEMOX alone in advanced biliary tract adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• Panitumumab (panitumumab)

Snippet

Sponsor: Prof. Massimo Aglietta | Conditions: Biliary Carcinoma | Phase 2 | Status: COMPLETED